Tazeprofen

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S05RV1R3LZ. European Medicines Agency schedules Tazeprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10846MIG. Tazeprofen generally arises in the molecular formula C16H13NO2S. The term TAZEPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24.) TAZEPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tazeprofen under HS 29341000 and SITC 51579. As of Q4 2014, TAZEPROFEN remains the US FDA Preferred Term for this commodity. Tazeprofen bears US NLM identifiers UMLS ID C2699897 and NCI Concept Code C76815. SMILES: S1C2CC(C(C)C(=O)O)CCC2NC1C1CCCCC1.